Biotechnology Assets, S.A. (BME:BST)
0.2160
0.00 (0.00%)
Nov 16, 2026, 3:32 PM CET
Biotechnology Assets Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.98 | 3.09 | 3.16 | 3.6 | 2.61 | 3.09 | |
Revenue Growth | -8.29% | -2.10% | -12.34% | 37.79% | -15.28% | 22.21% |
Cost of Revenue | 0.21 | 0.26 | 0.35 | 0.45 | 0.36 | 0.25 |
Gross Profit | 2.78 | 2.83 | 2.81 | 3.15 | 2.25 | 2.84 |
Selling, General & Admin | 2.36 | 2.44 | 2.95 | 2.96 | 2.56 | 3.33 |
Other Operating Expenses | -0.36 | -0.59 | -0.7 | -4.99 | -0.72 | -0.5 |
Operating Expenses | 3.89 | 3.86 | 4.45 | 0.44 | 3.99 | 4.91 |
Operating Income | -1.11 | -1.03 | -1.65 | 2.71 | -1.74 | -2.07 |
Interest Expense | -0.09 | -0.13 | -0.18 | -0.31 | -0.35 | -0.85 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.06 | -0.06 | -0.05 | -0.02 | 0.03 | 0.01 |
EBT Excluding Unusual Items | -1.26 | -1.22 | -1.87 | 2.38 | -2.05 | -2.91 |
Asset Writedown | -0.67 | -0.66 | -1.2 | -0.05 | - | - |
Other Unusual Items | 0.03 | 0.29 | 0.02 | 0 | 0.01 | 0 |
Pretax Income | -1.9 | -1.6 | -3.06 | 2.32 | -2.04 | -2.91 |
Income Tax Expense | 0.37 | 0.32 | -0.14 | 0.75 | -0.1 | 0.1 |
Earnings From Continuing Operations | -2.27 | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Net Income to Company | -2.27 | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Minority Interest in Earnings | 0 | 0 | - | -0 | 0 | 0 |
Net Income | -2.27 | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Net Income to Common | -2.27 | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 75 | - | 66 | 58 | 54 | 46 |
Shares Outstanding (Diluted) | 75 | - | 66 | 58 | 54 | 46 |
Shares Change | - | - | 14.28% | 6.50% | 18.82% | 16.39% |
EPS (Basic) | -0.03 | - | -0.04 | 0.03 | -0.04 | -0.07 |
EPS (Diluted) | -0.03 | - | -0.04 | 0.03 | -0.04 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.66 | -0.02 | -0.09 | -0.02 | -0.14 | -1.52 |
Free Cash Flow Per Share | -0.01 | - | -0.00 | - | -0.00 | -0.03 |
Gross Margin | 93.09% | 91.69% | 88.91% | 87.49% | 86.05% | 92.01% |
Operating Margin | -37.13% | -33.23% | -52.13% | 75.19% | -66.44% | -67.25% |
Profit Margin | -75.93% | -61.99% | -92.41% | 43.70% | -74.35% | -97.65% |
Free Cash Flow Margin | -22.05% | -0.49% | -2.77% | -0.61% | -5.54% | -49.24% |
EBITDA | -0.84 | -0.1 | -0.65 | 3.72 | -0.71 | -1.04 |
EBITDA Margin | -28.19% | -3.25% | -20.60% | 103.35% | -27.21% | -33.82% |
D&A For EBITDA | 0.27 | 0.93 | 1 | 1.01 | 1.03 | 1.03 |
EBIT | -1.11 | -1.03 | -1.65 | 2.71 | -1.74 | -2.07 |
EBIT Margin | -37.13% | -33.23% | -52.13% | 75.19% | -66.44% | -67.25% |
Effective Tax Rate | - | - | - | 32.23% | - | - |
Advertising Expenses | - | 0.02 | 0.05 | 0.04 | 0.01 | 0.05 |